Antibodies
23 October 2013
TRACON Pharmaceuticals Announces TRC105 Data Presented at the 2013 AACR-NCI-EORTC International Conference23 October 2013
ImmunoGen, Inc. Reports on Additions to Its Industry-Leading ADC Technology Portfolio at AACR-NCI-EORTC Conference23 October 2013
CytomX Therapeutics Presents Data for First-in-Class Jagged Probody™ Program at AACR-NCI-EORTC International Conference23 October 2013
FDA Grants Lilly’s Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer21 October 2013
Regeneron Reports Positive Phase 3 Data for EYLEA® (aflibercept) Injection in Macular Edema Following Branch Retinal Vein Occlusion21 October 2013
Seattle Genetics Initiates Phase 1 Trial of ADC Candidate, SGN-LIV1A, for Patients with LIV-1-Positive Metastatic Breast Cancer21 October 2013
ImmunoGen, Inc. Announces SAR566658 Clinical Findings Reported at AACR-NCI-EORTC Conference19 October 2013
Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis16 October 2013
Glycotope Reported Promising First-in-Man Data of Novel Glycooptimized Monoclonal Anti-TA-MUC1 Antibody PankoMab-GEX16 October 2013
INNATE PHARMA: presents proprietary antibody-drug conjugate technology at the World ADC Summit in San Francisco16 October 2013
Sutro Biopharma Presents Dual-Warhead Antibody Drug Conjugate at the World ADC Summit15 October 2013
Mersana Therapeutics Earns Milestone Payment in Fleximer-ADC Collaboration with Endo Pharmaceuticals11 October 2013
FDA Files Genentech’s Supplemental Biologics License Application of Xolair® (omalizumab) for Chronic Idiopathic Urticaria (CIU)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports